GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » ROE %

Malaysian Genomics Resource Centre Bhd (XKLS:0155) ROE % : -17.56% (As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Malaysian Genomics Resource Centre Bhd's annualized net income for the quarter that ended in Sep. 2023 was RM-5.79 Mil. Malaysian Genomics Resource Centre Bhd's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was RM32.98 Mil. Therefore, Malaysian Genomics Resource Centre Bhd's annualized ROE % for the quarter that ended in Sep. 2023 was -17.56%.

The historical rank and industry rank for Malaysian Genomics Resource Centre Bhd's ROE % or its related term are showing as below:

XKLS:0155' s ROE % Range Over the Past 10 Years
Min: -36.73   Med: -16.23   Max: 107.34
Current: -15.34

During the past 13 years, Malaysian Genomics Resource Centre Bhd's highest ROE % was 107.34%. The lowest was -36.73%. And the median was -16.23%.

XKLS:0155's ROE % is ranked worse than
59.91% of 212 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.235 vs XKLS:0155: -15.34

Malaysian Genomics Resource Centre Bhd ROE % Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd ROE % Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 -20.58 -21.51 107.34 -23.94

Malaysian Genomics Resource Centre Bhd Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.61 9.04 -12.55 -29.18 -17.56

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's ROE %

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's ROE % distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's ROE % falls into.



Malaysian Genomics Resource Centre Bhd ROE % Calculation

Malaysian Genomics Resource Centre Bhd's annualized ROE % for the fiscal year that ended in Jun. 2021 is calculated as

ROE %=Net Income (A: Jun. 2021 )/( (Total Stockholders Equity (A: Jun. 2020 )+Total Stockholders Equity (A: Jun. 2021 ))/ count )
=-4.293/( (0+17.93)/ 1 )
=-4.293/17.93
=-23.94 %

Malaysian Genomics Resource Centre Bhd's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-5.792/( (37.8+28.169)/ 2 )
=-5.792/32.9845
=-17.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-5.792/32.9845
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.792 / 9.06)*(9.06 / 37.913)*(37.913 / 32.9845)
=Net Margin %*Asset Turnover*Equity Multiplier
=-63.93 %*0.239*1.1494
=ROA %*Equity Multiplier
=-15.28 %*1.1494
=-17.56 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-5.792/32.9845
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5.792 / -5.956) * (-5.956 / -5.86) * (-5.86 / 9.06) * (9.06 / 37.913) * (37.913 / 32.9845)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9725 * 1.0164 * -64.68 % * 0.239 * 1.1494
=-17.56 %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Malaysian Genomics Resource Centre Bhd ROE % Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines